Since the 2022 overturning of Roe v. Wade, the landscape for reproductive health laws across the United States has been diverse and challenging. Certain states have responded with sweeping bans on abortion, rekindling the debate on women’s rights and freedom of choice. In contrast, others have taken proactive steps towards safeguarding reproductive rights.
This sentiment of divergence has been echoed in a conversation with advocacy groups; the Guttmacher Institute and the National Family Planning & Reproductive Health Association (NFPRHA). The organizations shed light on anticipated movements in 2024 and the major victories and setbacks in the field of reproductive health for 2023.
Kimya Forouzan, the Principal Policy Associate for State Issues at the Guttmacher Institute, highlighted the noteworthy second-highest number of abortion protection laws passed in 2023. These events underline the ongoing dedication of policymakers towards securing and amplifying abortion accessibility. In fact, Guttmacher Institute’s data indicates a surge in abortion rates in states where abortion remained lawful post-Roe v. Wade.
Additionally, six states, including Colorado, Maryland, Minnesota, New Mexico, Oregon, and Ohio, approved provisions that legally defend contraception usage. Oregon, Vermont, and Massachusetts also extended coverage or financial backing for gender-affirming treatments.
Kim Diaz Scott, the Vice President of Policy and Communications at NFPRHA, celebrated the reestablishment of the Right to Contraception Act plus the Food and Drug Administration’s sanction of Opill, the pioneer over-the-counter birth control pill in the U.S.
However, the substantial victories of 2023 were shadowed by several major setbacks. For instance, fourteen states have put absolute abortion prohibitions into action, two of which were enforced this year. Consequently, nearly 18 million women, along with trans and nonbinary individuals, are devoid of abortion care in their respective states, Forouzan noted. Moreover, legislative efforts to restrict or ban gender-affirming treatments have escalated significantly, with 19 states ratifying 20 such bans in 2023.
Concerns were also raised about the failure of Congress to raise funds for Title X. This shortfall impedes access to vital reproductive health services, particularly for low-income groups, according to Diaz Scott.
Amidst the ongoing struggles, Forouzan and Diaz Scott anticipate further challenges in 2024, including the restriction of interstate travel for abortion and a rise in misinformation about birth control. Nevertheless, they expect initiatives to protect reproductive health to continue, with Maryland and New York putting forward measures to improve reproductive health protections in the 2024 election ballot.
The whole story can be read at MedCity News.